VIM and neoplasm: Manouras et al. in their report showed that the tumour was immunonegative to most epithelial markers such as EMA, CEA, and AE1/AE3 but had focal positivity to CAM 5.2 and strong immunopositivity to mesenchymal markers (vimentin, SMA) [4].